GH Research PLC 4

Insider Michael Forer received two option awards for a total of 102,202 Ordinary Shares of GH Research PLC at a $0.025 exercise price.

On August 11, 2026, GH Research PLC reporting person Michael Forer received two grants of share options (rights to buy Ordinary Shares) at an exercise price of $0.025 per share. One grant covers 2,202 options that are immediately fully vested but not exercisable until August 11, 2028, and the other covers 100,000 options that vest and become exercisable as to 25% on August 11, 2027, with the remaining 75% vesting in equal monthly installments over the following three years, both expiring on August 11, 2033. These option grants are recorded as derivative awards with no immediate change in ownership of Ordinary Shares beyond the derivative-equivalent underlying share counts of 2,202 and 100,000, respectively, and represent routine equity-based compensation rather than open-market purchases or sales.

Filing Facts

CIK

1855129

Ticker

GHRS

Form

4

Source Type

fda

Accession

0001140361-26-032843

Alert Tier

5